Skip to main content
. 2018 Jun 15;57(12):1741–1745. doi: 10.2169/internalmedicine.0027-17

Table 2.

Laboratory Data.

WBC 4.85×103 /μL Cr 0.53 mg/dL HBsAg (-)
Hb 11.5 g/dL Na 143 mEq/L HBcAb (-)
Plt 13.0×104 /μL K 3.7 mEq/L HCVAb (-)
TP 6.9 g/dL Glu 82 mg/dL CMVIgM (-)
Alb 3.5 g/dL HbA1c 5.4 % EBV-VCAIgG 20
T-Bil 1.1 mg/dL CRP 0.26 mg/dL EBV-VCAIgM (-)
AST 78 U/L EBNA 40
ALT 42 U/L IgG 1,429 mg/dL
LDH 222 U/L IgA 239 mg/dL PT 52.6 %
γGTP 69 U/L IgM 89 mg/dL FDP 1.5> mg/mL
TCHO 153 mg/dL ANA ×320
TG 72 mg/dL AMA (-)

WBC: white blood cell, Hb: hemoglobin, Plt: platelet, TP: total protein, Alb: albumin, T-Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactase dehydrogenase, ALP: alkaline phosphatase, γ-GTP: gamma-glutamyltranspeptidase, TCHO: total cholesterol, TG: triglyceride, Cr: creatinine, Glu: glucose, HbA1c: hemoglobin A1c, CRP: C-reactive protein, ANA: antinuclear antibody, AMA: anti-mitochondrial antibodies, HBsAg: hepatitis B surface antigen, HBcAb: hepatitis B core antibody, HCVAb: anti-hepatitis C antibody, CMVIgM: cytomegalovirus IgM, EBV-VCA: Epstein-Barr virus-viral capsid antigen, EBNA: EBV nuclear antigen, PT: prothrombin time, FDP: fibrin degradation products